Primary Bile Acid Malabsorption

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Primary Bile Acid Malabsorption trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT01793168

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, i…

United States, Australia20,000 participantsStarted 2010-07

All recent trials (4 shown)

CompletedNot Applicable

NCT07235670

Gastrointestinal Hormone Secretion, Intestinal Permeability and Short Bowel Syndrome

The gastrointestinal tract is a complex endocrine organ that regulates a wide range of physiological processes, including those involved in the digestion of nut…

Denmark39 participantsStarted 2021-06-01

Treatment: Standardized meal

CompletedPhase 2

NCT01585025

Obeticholic Acid in Bile Acid Diarrhoea

The investigators propose to develop studies of obeticholic acid (OCA) in patients with bile acid diarrhoea. OCA is a semisynthetic bile acid, also known as 6αe…

United Kingdom35 participantsStarted 2012-04

Treatment: Obeticholic acid

Primary Bile Acid Malabsorption

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

All recent trials (4 shown)

Gastrointestinal Hormone Secretion, Intestinal Permeability and Short Bowel Syndrome

Obeticholic Acid in Bile Acid Diarrhoea

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

All recent trials (4 shown)

Gastrointestinal Hormone Secretion, Intestinal Permeability and Short Bowel Syndrome

Obeticholic Acid in Bile Acid Diarrhoea

To Assess Safety, Tolerability and Efficacy of LJN452 in Patients With Primary Bile Acid Diarrhea.